ETH269 8 mg (Doxazosin Mesylate 8 mg)

Pill with imprint ETH269 8 mg is Blue, Elliptical/Oval and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Ethex Corporation.

Doxazosin is used in the treatment of raynaud's syndrome; benign prostatic hyperplasia; high blood pressure and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ETH269 8 mg

Save up to 80% off prescription medications

Click here for your free Discount Card

Doxazosin Mesylate

Imprint

ETH269 8 mg

Strength

8 mg

Color

Blue

Size

12.00 mm

Shape

Elliptical/Oval

Availability

Prescription only

Drug Class

Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Ethex Corporation

National Drug Code (NDC)

58177-0269 (Discontinued)

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer